Home Cambridge Biotechnology

Cambridge Biotechnology

acquired
-
Developer of drugs for the treatment of clinical obesity
Basic
Enterprise Profile

Basic Information

Cambridge Biotechnology is involved in the discovery and development of drugs for the treatment of clinical obesity and pain. The company uses proprietary technology to develop lead compounds for diseases with significant medical needs.
Cambridge Biotechnology
Cambridge,England,United Kingdom
15~50 people
January 01, 2001
--
--

Enterprise Profile

Concept
Obesity # Pain